How is pollinosis treated in children?
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
In order to effectively treat pollinosis, along with rational pathogenetic therapy, an important role is played by the regime of the maximum possible limitation of the level of antigen stimulation. During the remission period, the main and most effective method of treating patients with pollinosis is specific hypo-sensitization.
Elimination of pollen is impossible.
Antihistamines for oral administration
Name of the drug |
Form of issue |
Doses and multiplicity of prescription | |
Commercial |
Generic (chemical) | ||
Preparations of the first generation | |||
Diazoline |
Mebrogroline |
Tablets of 0.05 and 0.1 |
Up to 2 years - 50-150 mg; from 2 to 5 years - 50-100 mg; from 5 to 10 years - 100-200 mg per day |
Peritol |
Cyproheptadine |
Tablets 0.004; syrup (1ml - 400mg) |
From 6 months. Up to 2 years (for special indications!) - 0.4 mg / kg per day; from 2 to 6 years - up to 6 mg per day; from 6 to 14 years - up to 12 mg per day; frequency of reception - 3 times a day |
Suprastin |
Chloropyramine |
Tablets 0.025 |
Up to 1 year - 6.25 mg; from 1 to 6 years - by 8.3 mg; from 6 to 14 years - 12.5 mg per appointment; frequency of reception - 2-3 times a day |
Tavegil |
Clemastine |
Tablets 0.001 |
From 6 to 12 years - to 0, 5 - 1, 0 mg; over 12 years - 1 mg per reception; frequency of reception - 2 times a day |
Phinehil |
Dimethindene maleate |
Drops for oral administration (1 ml = 20 drops = 1 mg); capsules 0.004 |
From 1 month. Up to 1 year - 3 to 10 drops; from 1 year to 3 years - 10-15 drops; older than 3 years - 15-20 drops per appointment; frequency of reception 3 times a day; children over 12 years - 1 capsule 1 time per day |
Fenkarol |
Hinuclidyl |
Tablets 0.01; 0.025 |
Up to 3 years - 5 mg; from 3 to 7 years - 10-15 mg; from 7 years and older - 15-25 mg per reception; frequency of reception 2-3 times a day |
Preparations of the second generation | |||
Zaditen, ketof, astafen, and others. |
Ketotifen |
Tablets 0.001; syrup (1 ml = 0.2 mg) |
From 1 year to 3 years - to 0.0005 mg; over 3 years - 0,001 mg per reception; frequency of reception - 2 times a day |
Zirtek |
Cetirizine |
Tablets 0.01; drops 10 ml (1 ml = 20 drops = 10 mg) |
Children over 2 years - 0.25 mg / kg, the frequency of reception - 1 - 2 times a day |
Claritin |
Loratadin |
Tablets 0.01; syrup (5 ml = 0.005) |
Children older than 2 years and with a body weight of up to 30 kg - 5 mg; with a body weight of more than 30 kg - 10 mg each; frequency of reception - once a day |
Preparations of the third generation | |||
Telfast |
Fexofenadine |
Tablets 0.12-0.18 |
Children over 12 years - 0.12 g or 0.18 g once a day |
In the treatment of allergic diseases, and in particular pollinosis, antihistamines are widely used. Antihistamines of the first generation have a sedative and cholinolytic effect, can cause the development of tachyphylaxis. However, these side effects are not observed in all patients. These drugs are effective for severe itching, vegetative dysfunction by vagotonic type. Fenkarol and peritol have an antiserotonin effect. Diphenhydramine and pipolpene are currently not used in children because of the high risk of side effects.
Antihistamines of the second generation do not penetrate the hemato-encephalic barrier and do not exert a pronounced sedative effect. They have a high affinity for H2 receptors, a rapid onset of action, a prolonged therapeutic effect, without causing tachyphylaxis. In addition to selective inhibition of histamine H2 receptors, second-generation drugs inhibit the early and late phases of an allergic reaction, have a combined antiallergic and anti-inflammatory effect. They are able to inhibit the release of histamine from mast cells and basophils, inhibit the production and release of leukotrienes, the formation of adhesion molecules of different classes, slow the flow of calcium into the cell, activate eosinophils and platelets.
Antihistamine preparation of the third generation of telphasts does not possess the cardiotoxic effect peculiar to some preparations of the second generation, it does not undergo biotransformation in the liver and, therefore, does not interact with other drugs metabolized in the liver by the cytochrome P450 system. The antihistamine effect begins after 1 hour, reaches a maximum after 6 hours and lasts for 24 hours. The drug is used prophylactically in the flowering season of etiologically significant plants. Telfast, zirtek and claritin are prescribed once a day.
Treatment of symptoms of allergic rhinitis is described in the chapter on allergic diseases of the respiratory tract. When allergic conjunctivitis is used optometrist, kromogling (solution kromoglicievoy acid for instillation into the eye).
Specific immunotherapy (SIT) is carried out by patients with polyvalent pollen sensitization (for example, trees and grass-weeds), which require a long daily intake of antihistamines and local treatment of symptoms of rhinitis and conjunctivitis. SIT is able to prevent the transformation of pollinosis into more severe forms of respiratory allergy.
Climatotherapy is shown with a change in the geographical zone for the flowering season of causally important plants.